[1]李 艳,赵 萱.非小细胞肺癌患者血管性血友病因子和微小RNA-497表达水平与肿瘤血管生成关系[J].陕西医学杂志,2024,(4):556-560.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.027]
　LI Yan,ZHAO Xuan.Relationship between the expression levels of von Willebrand factor and miRNA-497 and tumor angiogenesis in patients with non-small cell lung cancer[J].,2024,(4):556-560.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.027]
点击复制

非小细胞肺癌患者血管性血友病因子和微小RNA-497表达水平与肿瘤血管生成关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年4期
页码:
556-560
栏目:
临床病理
出版日期:
2024-04-05

文章信息/Info

Title:
Relationship between the expression levels of von Willebrand factor and miRNA-497 and tumor angiogenesis in patients with non-small cell lung cancer
作者:
李 艳; 赵 萱
(西安市中心医院呼吸与危重症医学科,陕西 西安 710004)
Author(s):
LI Yan; ZHAO Xuan
(Department of Respiratory and Critical Care Medicine,Xi'an Central Hospital,Xi'an 710004,China)
关键词:
非小细胞肺癌;  血管性血友病因子;  微小RNA-497;  癌变组织;  病理特征;  血管生成
Keywords:
Non-small cell lung cancer;  Von Willebrand factor;  miRNA-497;  Cancerous tissue;  Pathological features;  Angiogenesis
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.04.027
文献标志码:
A
摘要:
目的:探究血管性血友病因子(vWf)和微小RNA-497(miRNA-497)在非小细胞肺癌(NSCLC)患者中的表达情况及与肿瘤血管生成的关系。方法:收集102例接受手术根治治疗的NSCLC患者,免疫组化法测定患者癌变组织和对应癌旁组织(正常组织)中vWf表达情况和微血管密度(MVD),实时荧光定量聚合酶链反应(PCR)检测微小RNA-497(miRNA-497)表达情况。比较不同组织中vWf、miRNA-497表达水平,探究其表达水平与NSCLC患者MVD的关系。结果:癌变组织中vWf表达水平和MVD计数明显高于癌旁组织,miRNA-497表达水平明显低于癌旁组织(均P<0.05)。vWf在TNM Ⅲ-Ⅳ期、肿瘤细胞中低分化及出现淋巴转移的NSCLC癌变组织中表达水平明显提高,miRNA-497在该类患者癌变组织中表达水平明显下降(均P<0.05)。相关性分析显示,NSCLC癌变组织中vWf表达水平与MVD计数呈正相关(r=0.554),miRNA-497表达水平与MVD计数呈负相关(r=-0.707,P<0.01)。结论:vWf在NSCLC病灶组织中上调表达,miRNA-497下调表达,且其表达均与肿瘤细胞分化、侵袭、转移和血管新生有关。
Abstract:
Objective:To investigate the expression of von Willebrand factor(vWf)and miRNA-497 in patients with non-small cell lung cancer(NSCLC)and their relationship with tumor angiogenesis.Methods:102 patients with NSCLC who underwent radical surgical treatment were collected.The expression of vWf and microvessel density(MVD)in the cancerous tissues and corresponding adjacent tissues(normal tissues)were determined by immunohistochemistry,and real-time fluorescence quantitative polymerase chain reaction(PCR)was used to determine miRNA-497 expression in lung tissue.The expression levels of vWf and miRNA-497 in different tissues were compared,and which relationship between with MVD in NSCLC patients was analyzed.Results:Compared with the expression level of the adjacent tissues of NSCLC patients,the expression level of vWf in the cancerous tissues was increased,the number of MVD was increased,and the level of miRNA-497 was decreased(all P<0.05).The expression level of vWf was significantly increased in TNM Ⅲ to Ⅳ stage,poorly differentiated NSCLC tissues and lymphatic metastases,and the expression level of miRNA-497 was significantly decreased in these patients(all P<0.05).Correlation analysis showed that there was a positive correlation between the expression of vWf in NSCLC cancerous tissues and the number of MVD,while the expression level of miRNA-497 was negatively correlated with MVD count(r=0.554,-0.707,all P<0.01).Conclusion:The expression of vWf is up-regulated,and miRNA-497 down-regulated in NSCLC focal tissues,and its expression is correlated with tumor cell differentiation,invasion,metastasis and angiogenesis.

参考文献/References:

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] ZHANG S,SUN K,ZHENG R,et al.Cancer incidence and mortality in China,2015[J].J Nation Canc Cent,2021,1(1):2-11.
[3] 李岚,许斌,武杰,等.原发灶手术对Ⅳ期非小细胞肺癌患者生存的影响[J].中华肿瘤杂志,2021,43(3):335-344.
[4] JASPER K,STILES B,MC-DONALD F,et al.Practical management of oligometastatic Non-small-cell lung cancer[J].J Clin Oncol,2022,40(6):635-641.
[5] MENG C,LIU K,CAI X,et al.Mechanism of miR-455-3 in suppressing epithelial-mesenchymal transition and angiogenesis of non-small cell lung cancer cells[J].Cell Stress Chaperones,2021,27(2):107-117.
[6] TAO Q,QI Y,GU J,et al.Breast cancer cells-derived von willebrand factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway[J].Toxicol Appl Pharmacol,2022,440(1):115927-115933.
[7] ZHANG Y,ZHANG Z,LI Z,et al.MicroRNA-497 inhibits the proliferation,migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3[J].Oncol Rep,2020 43(3):1032.
[8] YE R,LU X,LIU J,et al.CircSOD2 contributes to tumor progression,immune evasion and anti-PD-1 resistance in hepatocellular carcinoma by targeting miR-497-5p/ANXA11 axis[J].Biochem Genet,2023,61(2):597-614.
[9] YUDIN D I,LAKTIONOV K K,SARANTSEVA K A,et al.Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N.blokhin russian cancer research center[J].Med Council,2021,1(9):18-24.
[10] 崔凯,白峻峰,支亚男,等.外泌体微小RNA-23a对非小细胞肺癌血管生成的影响及机制研究[J].陕西医学杂志,2021,50(9):1048-1051,1055.
[11] 郑茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,42(7):844-848.
[12] NAVONE S E,DONISELLI F M,SUMMERS P,et al.Correlation of preoperative Von Willebrand factor with magnetic resonance imaging perfusion and permeability parameters as predictors of prognosis in glioblastoma[J].World Neurosurg,2019,122(1):226-234.
[13] 王欣怡,张琼文,沈永明,等.血浆vWF和ADAMTS-13在评估VSD患儿术后血管内皮损伤及预后中的应用价值[J].中国实验血液学杂志,2023,31(1):189-196.
[14] 刘旭,吴宿慧,陈小菲,等.基于vWF/GPIb-IX-V信号通路的丹红注射液对急性血瘀大鼠模型活血化瘀作用及机制研究[J].中草药,2023,54(4):1173-1183.
[15] PATMORE S,DHAMI S P S,O'SULLIVAN J M.Von Willebrand factor and cancer; metastasis and coagulopathies[J].J Thromb Haemost,2020,18(10):2444-2456.
[16] GOH C Y,PATMORE S,SMOLENSKI A,et al.The role of von Willebrand factor in breast cancer metastasis[J].Transl Oncol,2021,14(4):101033-101041.
[17] 司晓丽,李双燕,郭超,等.在不同转移潜能人肺癌细胞移植瘤中血管性血友病因子的表达[J].基础医学与临床,2020,40(3):346-350.
[18] 梁汉霖,彭杰文,张俊凯,等.miR-10b通过调节vWF抑制肺癌细胞侵袭和迁移[J].中华肿瘤防治杂志,2017,44(16):313-315.
[19] 曹祥,羊玲,罗海伶.血浆miRNA-497在小儿脓毒症心肌损伤早期诊断中的应用价值[J].临床和实验医学杂志,2020,19(18):1945-1948.
[20] 项涛,雷慧,谭绮琼,等.IL-27、IL-29及miRNA-497在HER-2阳性胃癌患者放射性粒子联合靶向治疗中的价值[J].重庆医学,2017,46(30):4204-4206.
[21] 刘少平,谈惠群,胡亚华,等.血清microRNA-497定量检测与结直肠癌血管生成的关系及其临床意义[J].实用医学杂志,2020,36(17):2404-2408.
[22] XIE Y X,ZHOU Z H,LIU S W,et al.MicroRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target QKI[J].Aging(Albany NY),2023,15(9):3791-3806.
[23] GARASHCHENKO O,KONOVALENKO V.Analysis of plasma miRNA-497 levers in the blood of patients with breast cancer[J].Georgian Med News,2023,1(340-341):212-216.
[24] YU Y,WANG Y,JIA T,et al.Mechanism of SNHG12 in regulating human angiostatin binding protein through microRNA497 in the migration and invasion of human lung cancer cells[J].Anticancer Res,2022,6(5):85-90.
[25] JEONG K,YU Y J,YOU J Y,et al.Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model[J].Lab Chip,2020,20(3):548-557.

相似文献/References:

[1]王晓东,景鹏宇△,崔 凯,等.术前外周血中性粒细胞淋巴细胞比值对ⅠⅢ期非小细胞肺癌患者预后的影响[J].陕西医学杂志,2019,(12):1612.
[2]彭 峰,彭奕华,张宏华,等.非小细胞肺癌化疗前后血清糖类抗原125、肿瘤异常蛋白水平变化及其与疗效的关系[J].陕西医学杂志,2020,49(7):851.[doi:DOI:10.3969/j.issn.10007377.2020.07.023]
　PENG Feng,PENG Yihua,ZHANG Honghua,et al.Changes of serum CA125 and TAP levels before and after chemotherapy for non-small cell lung cancer and their relationship with curative effect[J].,2020,49(4):851.[doi:DOI:10.3969/j.issn.10007377.2020.07.023]
[3]杨 昕,刘 芳,杜 静,等.肺癌癌组织中过氧化物酶增殖体激活受体γ基因表达水平对培美曲塞化疗疗效的预测价值*[J].陕西医学杂志,2020,49(10):1359.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.042]
　YANG Xin,LIU Fang,DU Jing,et al.Predictive value of PPARγ gene expression level in lung cancer tissue for curative effect of pemetrexed chemotherapy[J].,2020,49(4):1359.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.042]
[4]王晓东,吕 峰△,崔 凯.ⅢA-N2期非小细胞肺癌纵隔淋巴结跳跃性转移临床特点及对预后的影响[J].陕西医学杂志,2020,49(12):1634.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.025]
[5]苏艳丽,李 波.Th9细胞对非小细胞肺癌患者CD8+T细胞抗肿瘤活性的调控作用[J].陕西医学杂志,2021,50(1):15.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.004]
　SU Yanli,LI Bo.Regulatory of Th9 cells on anti-tumor activity of CD8+T cells in patients with non-small-cell lung cancer[J].,2021,50(4):15.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.004]
[6]岳 英,董锦华,肖月梅.肺免疫微环境中调节因子表达对肿瘤生长和转移的影响[J].陕西医学杂志,2021,50(4):495.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.030]
[7]崔 凯,白峻峰,支亚男,等.外泌体微小RNA-23a对非小细胞肺癌血管生成的影响及机制研究[J].陕西医学杂志,2021,50(9):1048.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.002]
　CUI Kai,BAI Junfeng,ZHI Ya'nan,et al.Effect of exosome miR-23a on angiogenesis in NSCLC and its mechanism[J].,2021,50(4):1048.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.002]
[8]陈 彦,姜立朋.基于CT的影像组学特征对非小细胞肺癌放射治疗效果的评估价值[J].陕西医学杂志,2021,50(9):1094.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.013]
　CHEN Yan,JIANG Lipeng.Evaluation value of CT-based imaging omics features for radiotherapy effect in treatment of non-small cell lung cancer[J].,2021,50(4):1094.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.013]
[9]崔 凯,支亚男,王壮壮,等.微小RNA-30对非小细胞肺癌侵袭、转移能力的影响及机制研究[J].陕西医学杂志,2021,50(10):1214.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.009]
　CUI Kai,ZHI Ya'nan,WANG Zhuangzhuang,et al.Effect and mechanism of miR-30 on invasion and metastasis of non-small cell lung cancer[J].,2021,50(4):1214.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.009]
[10]梁乐乐,王 鹏,刘俊霞,等.非小细胞肺癌组织中T细胞免疫球蛋白区黏蛋白-3、程序性死亡因子-1及程序性因子配体1的表达分析[J].陕西医学杂志,2021,50(10):1227.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.012]
　LIANG Lele,WANG Peng,LIU Junxia,et al.Expression of TIM-3,PD-1 and PD-L1 in non-small cell lung cancer[J].,2021,50(4):1227.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.012]

备注/Memo

备注/Memo:
基金项目:陕西省卫生厅科研项目(2010D38)
更新日期/Last Update: 2024-04-07